Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
13
currently held
Exits tracked
6
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capital
Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks agoCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminLauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month agoBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin19 companies matching
Biodextris
MED Rise
Canada
Sector
Biotech
InvestorARCHIMED
Entry
2024
Hold
0yr
Exit
2024
to MED Bio
Fusion Pharmaceuticals Inc.
HealthCap VII
Canada
Sector
Biotech
InvestorHealthCap
Entry
2017
Hold
7yr
Exit
2024
to AstraZeneca
Reunion Neuroscience
Novo Holdings Venture Investments
Canada
Sector
Biotech
InvestorNovo Holdings
Entry
2022
Hold
2yr
Exit
2024
to MPM BioImpact
Northern Biologics
Criteria Bio Ventures
Canada
Sector
Biotech
InvestorCaixa Capital Risc
Entry
2016
Hold
4yr
Exit
2020
to Boehringer Ingelheim
Caprion Biosciences
GHO Capital Fund I LP
Canada
Sector
Biotech
InvestorGHO Capital
Entry
2016
Hold
3yr
Exit
2019
to Arsenal Capital Partners
Edesa Biotech
Inveready Biotech II
Canada
Sector
Biotech
InvestorInveready Asset Management
Entry
2017
Hold
2yr
Exit
2019
AmacaThera
Inveready Biotech III
Canada
Sector
Biotech
InvestorInveready Asset Management
Entry
2020
Hold
6yr
Comet Biorefining
Sofinnova Capital IX
Canada
Sector
Biotech
InvestorSofinnova Partners
Entry
2019
Hold
7yr
Congruence Therapeutics
Angelini Ventures
Canada
Sector
Biotech
InvestorAngelini Ventures
Entry
2021
Hold
5yr
Damona Pharmaceuticals
Angelini Ventures
Canada
Sector
Biotech
InvestorAngelini Ventures
Entry
2022
Hold
4yr
Find Therapeutics
Cap Innov'Est 2
Canada
Sector
Biotech
InvestorCapital Grand Est
Entry
–
Gandeeva Therapeutics
Leaps by Bayer
Canada
Sector
Biotech
InvestorLeaps by Bayer
Entry
2022
Hold
4yr
Kainova Therapeutics
Health for Life Capital
Canada
Sector
Biotech
InvestorSeventure Partners
Entry
2026
Hold
0yr
Nimble Sciences
Health for Life Capital
Canada
Sector
Biotech
InvestorSeventure Partners
Entry
2023
Hold
3yr
DreamFold
IQ Capital Fund IV
Canada
Sector
Biotech
InvestorIQ Capital Partners
Entry
2025
Hold
1yr
Esperas
TVM Life Science Ventures
Canada
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2015
Hold
11yr
Novobind
Health for Life Capital
Canada
Sector
Biotech
InvestorSeventure Partners
Entry
2022
Hold
4yr
Ocellaris Pharma
TVM Life Science Innovation
Canada
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2019
Hold
7yr
Sarkana Pharma, Inc.
TVM Life Science Innovation
Canada
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2021
Hold
5yr